Peptide TherapeuticsPeer Reviewed
Updated guidelines in the treatment of myeloma bone disease in 2025: consensus statement by the Medical and Scientific advisory group of Australia (MSAG) to myeloma australia.
Authors (11)
Angelina Yong
Kate Vandyke
Bradley AugustsonDepartment of Haematology, Sir Charles Gairdner Hospital, Western, Australia.
Georgia McCaughanHaematology Department, the Kinghorn Cancer Centre, St Vincent's Hospital New South Wales.
Expert review of hematology
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
bisphosphonatesdenosumabfractureslytic lesionsmultiple myelomamyeloma bone diseaseosteonecrosis of the jawrenal impairmentzoledronic acid
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.